Your Hospital’s 340B Contract Pharmacy Network Is Not What It Should Be.

November 15, 2023340B, Contract Pharmacy, Covered Entities, Drug Manufacturer Restrictions, Patient Eligibility, PBM, Prescription Discounts, Specialty Drugs, Specialty Drugs, Specialty Pharmacy, Specialty Pharmacy, TPA / TPAs, Uncategorized

Based on our experience, it’s a claim we can make with 100% certainty. Since 2019, when ProxsysRx launched its 340B Support Services division, we’ve managed the 340B programs of 18 health systems. Altogether, we’ve generated more than $500 million in 340B Savings and Revenue for those health systems — $98M in the first 10 months … Read More

How 340B Programs Can Positively Impact Value-Based Care Scores

March 9, 2023340B, Bedside Prescription Delivery, CMS Star Ratings, Covered Entities, Medicare, Medication Compliance, Meds To Beds, Meds To Beds, Outpatient Tracking, Overview, Patient Eligibility, Readmissions Reduction, Value-Based Care

It’s no secret that, for hospitals, one of the Affordable Care Act’s most far-reaching legacies is the impact that Value-Based Care has on the payments they receive. For many health systems, the lower their Value-Based Care scores, the lower the payments they receive from treating Medicare and Medicaid patients. What isn’t as commonly considered — … Read More

How To Manage A Director of Pharmacy’s Responsibilities And An Optimized 340B Program. Without Hiring More Staff.

November 9, 2022340B, 340B ESP, Bedside Prescription Delivery, Compliance, Contract Pharmacy, Meds To Beds, Outpatient Tracking, Patient Eligibility, Retail / Outpatient Pharmacy, Specialty Pharmacy

Two DOPs Deal With Operations, The 340B Program, And Drug Manufacturers’ Restrictions ProxsysRx recently organized an introductory Zoom meeting between the DOPs of two health systems we serve. Southwest Mississippi Regional Medical Center’s (SMRMC) Tiffany Poole earned her Doctorate of Pharmacy degree from the University of Mississippi in 2006. A ProxsysRx pharmacist since 2018, she … Read More

What Is Your Health System’s Potential ROI With An Optimized 340B Program?

October 24, 2022340B, 340B ESP, Contract Pharmacy, Overview, Patient Eligibility, Specialty Drugs, Specialty Pharmacy

Introducing ProxsysRx’s 340B Program ROI Calculator The 340B program has often been described, and with good reason, as a black box. There are dozens of factors impacting an individual hospital’s relative success or failure in generating positive returns from a program. ProxsysRx has optimized dozens of 340B programs — generating tens of millions in savings … Read More

340B Best Practices You Need To Know

April 1, 2022340B, Audit, Bedside Prescription Delivery, Compliance, Contract Pharmacy, Covered Entities, Meds To Beds, Overview, Patient Eligibility, Requirements, Specialty Pharmacy, Specialty Pharmacy

If your hospital is 340B-eligible, you may be missing-out on millions of dollars in prescription reimbursements. Savings and revenue which, for some hospitals served by ProxsysRx, actually make the difference between solvency and closure. Any list of Best Practices for running a 340B program starts with maintaining compliance. Tips for maintaining 340B Program Compliance The … Read More

What is 340B Double-Dipping, and How Can You Avoid It?

March 25, 2022340B, Compliance, Contract Pharmacy, Covered Entities, Patient Eligibility, Registration, Requirements

The 340B drug pricing program allows eligible providers to replenish prescriptions to eligible patients at significantly reduced pricing, and bill normal market rates for those prescriptions —helping the entities fill revenue gaps that are inherent to their business models. That said, the program does not allow eligible providers to take advantage of 340B discounts and … Read More